Primary progressive aphasia (PPA) is a relatively common clinical neurodegenerative syndrome that first and foremost affects language abilities. PPA usually has an early onset (50-60 years of age), detrimentally affecting work and family life. Spelling is one of the earliest affected language skills with significant prognostic and diagnostic value for its course.
There is no available treatment for affected individuals. Behavioral language therapy and written naming and spelling interventions in particular have shown modest but encouraging gains, which, however, do not generalize to untrained items and do not sustain over time.
Transcranial Direct Current Stimulation (tDCS) is a relatively new, safe, non-invasive, non-painful electrical stimulation of the brain; it has been shown to improve language and cognitive abilities in healthy controls and individuals with stroke and dementia when administered during language therapy. Repetitive and consecutive sessions of tDCS are thought to induce a type of long-term potentiation in the brain that affects synaptic connectivity.
In this project we investigate the behavioral and neuromodulatory effects of tDCS during spelling therapy in PPA participants over time.
In Specific Aim 1, we will test the hypothesis that anodal tDCS, when administered in combination with spelling therapy, will improve spelling performance of individuals with PPA more than behavioral written naming/spelling therapy alone. We also hypothesize that improvements will be sustained over time and generalize to other language and cognitive functions subserved by the stimulated brain areas.
In Specific Aim 2, we test the hypothesis that changes in functional connectivity as measured by resting-state fMRI are greater after tDCS coupled with spelling intervention than after behavioral spelling intervention alone while controlling for grey matter volume and white matter tract loss as measured by volumetric and diffusion tensor imaging (DTI).
Study results may help optimize future interventions in individuals with PPA or other neurodegenerative disease by providing novel treatment alternatives in a neurodegenerative syndrome with no proven effective treatment. A better understanding of the behavioral as well as functional connectivity changes due to tDCS will offer insights into ways of impeding neurodegeneration that may improve quality of life for individuals with PPA and other dementias.
Please contact us to learn more!